Literature DB >> 11160362

Impaired hepatic fatty acid oxidation in rats with short-term cholestasis: characterization and mechanism.

C Lang1, M Schäfer, D Serra, F Hegardt, L Krähenbühl, S Krähenbühl.   

Abstract

Rats with long-term cholestasis have reduced ketosis during starvation. Because it is unclear whether this is also the case in short-term cholestasis, we investigated hepatic fatty acid metabolism in rats with bile duct ligation for 5 days (BDL5, n = 11) or 10 days (BDL10, n = 11) and compared the findings with those made with pair-fed control rats (CON5 and CON10, n = 11). The plasma beta-hydroxybutyrate concentration was reduced in BDL rats (0.54 +/- 0.10 vs. 0.83 +/- 0.30 mM at 5 days and 0.59 +/- 0.24 vs. 0.88 +/- 0.09 mM at 10 days in BDL and control rats, respectively). In isolated liver mitochondria, state 3 oxidation rates for various substrates were not different between BDL and control rats. Production of ketone bodies from [(14)C]palmitate was reduced by 40% in mitochondria from BDL rats at both time points, whereas production of (14)CO(2) was maintained. These findings indicated intact function of the respiratory chain, Krebs cycle, and beta-oxidation and suggested impaired ketogenesis (HMG-CoA pathway). Accordingly, the formation of acetoacetate from acetyl-CoA by disrupted mitochondria was reduced in BDL rats at 5 days (2.1 +/- 1.0 vs. 4.8 +/- 1.9 nmol/min per mg protein) and at 10 days (1.7 +/- 1.0 vs. 6.2 +/- 1.9 nmol/min per mg protein). The principal defect could be localized at the rate-limiting enzyme of the HMG-CoA pathway, HMG-CoA synthase, which revealed decreased activity, and reduced hepatic mRNA and protein levels. We conclude that short-term cholestasis in rats leads to impaired hepatic fatty acid metabolism due to impaired ketogenesis. Ketogenesis is impaired because of decreased mRNA levels of HMG-CoA synthase, leading to reduced hepatic protein levels and to decreased activity of this key enzyme of ketogenesis. - Lang, C., M. Schäfer, D. Serra, F. G. Hegardt, L. Krähenbühl, and S. Krähenbühl. Impaired hepatic fatty acid oxidation in rats with short-term cholestasis: characterization and mechanism. J. Lipid Res. 2001. 42: 22;-30.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11160362

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  5 in total

1.  Time course of acylcarnitine elevation in neonatal intrahepatic cholestasis caused by citrin deficiency.

Authors:  Ni-Chung Lee; Yin-Hsiu Chien; Keiko Kobayashi; Takeyori Saheki; Huey-Ling Chen; Pao-Chin Chiu; Yen-Hsuan Ni; Mei-Hwei Chang; Wuh-Liang Hwu
Journal:  J Inherit Metab Dis       Date:  2006-05-30       Impact factor: 4.982

2.  Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Lauren N Bell; Jacob Wulff; Megan Comerford; Raj Vuppalanchi; Naga Chalasani
Journal:  Liver Int       Date:  2014-09-22       Impact factor: 5.828

3.  The specific molecular architecture of plant 3-hydroxy-3-methylglutaryl-CoA lyase.

Authors:  Andréa Hemmerlin; Alexandre Huchelmann; Denis Tritsch; Hubert Schaller; Thomas J Bach
Journal:  J Biol Chem       Date:  2019-09-12       Impact factor: 5.157

4.  In vivo monitoring of hepatic glycolipid distribution of n-6 ∕ n-3 in jugular-vein-cannulated rats as a nutritional research model for monogastric animal.

Authors:  Sang-O Park; Victor A Zammit
Journal:  Arch Anim Breed       Date:  2019-07-19

5.  Mitochondrial Mutations in Cholestatic Liver Disease with Biliary Atresia.

Authors:  Hong Koh; Gun-Seok Park; Sun-Mi Shin; Chang Eon Park; Seung Kim; Seok Joo Han; Huy Quang Pham; Jae-Ho Shin; Dong-Woo Lee
Journal:  Sci Rep       Date:  2018-01-17       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.